Makers Laboratories Limited share price
NSE: MAKERSL · ISIN INE987A01010
Key numbers
- Market cap
- ₹ 111 Cr
- Current price
- ₹ 188.40
- 52-week high / low
- ₹ 236 / 150
- Stock P/E
- 32.5
- Book value
- ₹ 123.6
- Dividend yield
- 0.00%
- ROCE
- 15.4%
- ROE
- 3.3%
- Debt to equity
- 0.08
- Sales growth (3 yrs)
- 11.4%
- Profit growth (3 yrs)
- -
- 1-year return
- -
About Makers Laboratories Limited
Makers Laboratories Limited, an integrated pharmaceutical company, manufactures and markets formulations in India. It operates in two segments, Pharmaceutical and Chemical Manufacturing. The company offers general health therapeutic products, including acid regulatory, anthelmintic, anti-allergic, anti-asthmatic, anti-biotic, anti-diabetics, anti-diarrhoeals, anti-emetics and anti-nauseants, anti-fungal, anti-hypertensive, antiinflammatory, analgesic, anti-spasmodic, anti-malarial, and anti-thyroid. It also provides cough and cold control, digestives, neurotonics, nutritional supplements, topical anti-biotic/anti-microbial, and other specialty drugs. The company sells its products under the Duramol, Artemak-AB, Loroquin, Nimuwin, Coffwin, and Exylin brands. It distributes its products through agents, stockiest, doctors, and retailers. The company also exports its products. Makers Laboratories Limited was incorporated in 1984 and is based in Mumbai, India.
Quarterly results
Consolidated figures in ₹ crores
| Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|
| Sales | 35 | 34 | 36 | 36 | 43 |
| Operating profit | 3 | 2 | 4 | 5 | 7 |
| Net profit | 0 | -0 | 1 | 1 | 2 |
| EPS (₹) | 0.74 | -0.20 | 1.59 | 1.85 | 2.55 |
Peers in Drug Manufacturers - Specialty & Generic
Data for information only, not investment advice. Prices end of day.